{
  "$type": "site.standard.document",
  "bskyPostRef": {
    "cid": "bafyreiejmb2fcut6jxj2y6jyraneozpfuf25pz265s3ni5wd65ehmosgkm",
    "uri": "at://did:plc:5ka4qkui7nvjms7idhte2m4o/app.bsky.feed.post/3mhyzmntekuu2"
  },
  "coverImage": {
    "$type": "blob",
    "ref": {
      "$link": "bafkreidvev667p3jtiu64vmfqwxstmuj7llqrgn6uduell6k7bwsae42zm"
    },
    "mimeType": "image/jpeg",
    "size": 63693
  },
  "path": "/2026/03/26/rocket-pharma-kresladi-lad-1-fda-approval/?utm_campaign=rss",
  "publishedAt": "2026-03-27T00:42:07.000Z",
  "site": "https://www.statnews.com",
  "tags": [
    "Biotech",
    "biotechnology",
    "Gene therapy",
    "rare diseases",
    "STAT+"
  ],
  "textContent": "Kresladi has been tested in just nine patients but has had positive results.",
  "title": "STAT+: FDA approves Rocket gene therapy for rare immune disorder",
  "updatedAt": "2026-03-27T00:59:18.000Z"
}